Metabolomics Profiles and Prognostic Biomarkers in Sepsis Survivors and Nonsurvivors
Abstract
INTRODUCTION
Sepsis imposes an overwhelming global critical care burden, contributing to an estimated 49 million annual deaths worldwide. Although multiple sepsis-related metabolic profiles have been characterized in prior research, no metabolomic biomarkers have yet entered routine clinical prognostic practice. This study aimed to identify actionable serum metabolite biomarkers to stratify 28-d mortality risk among adult sepsis patients.
METHODS
We performed high-resolution untargeted serum metabolomics to profile molecular signatures across three cohorts: 60 sepsis nonsurvivors, 60 sepsis survivors, and 20 age- and sex-matched healthy controls (HCs). Supervised partial least squares discriminant analysis implemented via MetaboAnalyst 5.0 was used to screen differential circulating metabolites. Receiver operating characteristic curve analysis quantified the predictive performance of candidate metabolites for sepsis mortality. The correlations between differential metabolite concentrations and clinical laboratory/severity indices were analyzed using R software.
RESULTS
Partial least squares discriminant analysis models demonstrated clear metabolic separation among HCs, sepsis survivors, and nonsurvivors. Pairwise comparison identified 1092 differential metabolites between survivors and HCs, 757 metabolites between survivors and nonsurvivors, and 1230 metabolites between nonsurvivors and HCs. A core set of 200 mortality-linked metabolites was enriched in five canonical Kyoto…
Read the paper
Related studies
- Diagnosis and management of glutaric aciduria type I – revised recommendations
- EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
- Consensus guidelines for the diagnosis and management of pyridoxine‐dependent epilepsy due to α‐aminoadipic semialdehyde dehydrogenase deficiency
- Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry
- Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
- Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.